MRK Merck & Company, Inc. Common Stock (new)
$137,61
Prezzo · Ago 18, 2026
Fondamentali al Ago 7, 2026
Intervallo 52 sett.
$78–$138
99% of range
Rating Analisti
BUY
36 analysts
Prezzo Obiettivo
$137
P/E (TTM)
14.5
ROE
36.9%
Margine di Profitto Netto
28.1%
Informazioni su Merck & Company, Inc. Common Stock (new) Panoramica della società da Wikipedia
Merck & Co., Inc. è una delle più grandi società farmaceutiche del mondo. Il suo quartier generale è situato a Readington, New Jersey. In Italia, invece, la società ha sede a Roma.
Leggi di più
Merck & Co., Inc. (conosciuta anche come Merck Sharp & Dohme o MSD al di fuori di Stati Uniti e Canada) è una delle più grandi società farmaceutiche del mondo. Il suo quartier generale è situato a Readington, New Jersey. In Italia, invece, la società ha sede a Roma.
Storia
È stata fondata nel 1891 come la filiale statunitense della società tedesca ora nota come Merck KGaA da Theodore Weicker e George Merck. Come per molte altre attività tedesche negli Stati Uniti, Merck & Co. fu confiscata nel 1917 durante la prima guerra mondiale e si costituì come società indipendente.
Merck & Co. o MSD si definisce "una società globale guidata dalla ricerca farmaceutica". Merck scopre, sviluppa, produce e commercializza una vasta gamma di prodotti innovativi per migliorare la salute umana e animale (MSD Animal Health), direttamente e attraverso le joint ventures. La Fondazione Merck ha distribuito oltre 160 milioni di dollari ad organizzazioni educative e non-profit da quando è stata fondata nel 1957.
Nel 2011 l'azienda è stata condannata a pagare una multa di 950 milioni di $ per aver nascosto importanti dati sulla sicurezza di un suo farmaco antifiammatorio attuando pratiche di disease mongering.
Pubblicazioni
Merck pubblica il Merck Manual of Diagnosis and Therapy (Manuale Merck di diagnosi e terapia), e fino al 2012 ha pubblicato il Merck Index, una raccolta di informazioni sui composti chimici.
Fonte: Wikipedia, CC BY-SA 4.0 · Vedi su Wikipedia ↗
MRK Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$137.61
Capitalizzazione di Mercato
—
P/E (TTM)
14.5
EPS (TTM)
$7.28
Ricavi (TTM)
$65.01B
Rendimento div.
—
ROE
36.9%
D/E Debito/Patrimonio
0.9
Intervallo 52 sett.
$78 – $138
MRK Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$65.01B
2016-12-31
→
2025-12-31
EPS
$7.28
2016-12-31
→
2025-12-31
Flusso di cassa libero
$12.36B
2016-12-31
→
2025-12-31
Margini
28.1%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
MRK
Mediana dei peer
P/E (TTM)
14.5
32.1
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
MRK
Mediana dei peer
Net Profit Margin (Margine di Profitto Netto)
28.1%
13.0%
ROA
14.4%
6.4%
ROE
36.9%
15.1%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
MRK
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
0.9
—
Current Ratio (Rapporto corrente)
1.5
1.6
Quick Ratio
0.9
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
MRK
Mediana dei peer
Revenue YoY (Ricavi YoY)
1.3%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
3.1%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
9.4%
—
EPS YoY
8.0%
—
Net Income YoY (Utile Netto YoY)
6.6%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
MRK
Mediana dei peer
Payout Ratio (Rapporto di Distribuzione Utili)
44.8%
—
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Dividend Yield
—
Rapporto di Distribuzione Utili
44.8%
CAGR Dividendi 5Y
—
| Data ex-dividendo | Importo |
|---|---|
| 15 Giugno 2026 | $0,8500 |
| 16 Marzo 2026 | $0,8500 |
| 15 Dicembre 2025 | $0,8500 |
| 15 Settembre 2025 | $0,8100 |
| 16 Giugno 2025 | $0,8100 |
| 17 Marzo 2025 | $0,8100 |
| 16 Dicembre 2024 | $0,8100 |
| 16 Settembre 2024 | $0,7700 |
| 17 Giugno 2024 | $0,7700 |
| 14 Marzo 2024 | $0,7700 |
| 14 Dicembre 2023 | $0,7700 |
| 14 Settembre 2023 | $0,7300 |
| 14 Giugno 2023 | $0,7300 |
| 14 Marzo 2023 | $0,7300 |
| 14 Dicembre 2022 | $0,7300 |
| 14 Settembre 2022 | $0,6900 |
| 14 Giugno 2022 | $0,6900 |
| 14 Marzo 2022 | $0,6900 |
| 14 Dicembre 2021 | $0,6900 |
| 14 Settembre 2021 | $0,6500 |
MRK Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
36 analisti
- Acquisto forte 9 25,0%
- Compra 16 44,4%
- Mantieni 11 30,6%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
26 analisti · 2026-08-15
Mediana
$141.50
Media
$136.85
Ora
$137.61
Basso
$105.00
Alto
$155.00
Target mediano
$141.50
+2,8%
Target medio
$136.85
-0,6%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.16%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.13 | $-0.27 | 0.14% |
| 31 Marzo 2026 | $-1.28 | $-1.52 | 0.24% |
| 31 Dicembre 2025 | $2.09 | $2.03 | 0.06% |
| 30 Settembre 2025 | $2.68 | $2.37 | 0.31% |
| 30 Giugno 2025 | $2.19 | $2.03 | 0.16% |
| 31 Marzo 2025 | $2.22 | $2.16 | 0.06% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| MRK | — | 14.5 | 1.3% | 28.1% | 36.9% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
| JNJ | — | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| PFE | — | 18.3 | -1.7% | 12.4% | 8.9% | — |
| BMY | — | 15.6 | -0.22% | 14.6% | 40.5% | — |
| RPRX | — | 21.7 | 5.1% | 32.4% | 8.0% | — |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | — |
| VTRS | — | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | — |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.01B | $64.17B | $60.12B | $59.28B | $48.70B | $41.52B | $39.12B | $42.29B | $40.12B | $39.81B | $39.50B | $42.24B | |
| Cost of Revenue | $16.38B | $15.19B | $16.13B | $17.41B | $13.63B | $13.62B | $12.02B | $13.51B | $12.91B | $14.03B | $14.93B | $16.77B | |
| R&D Expense | $15.79B | $17.94B | $30.53B | $13.55B | $12.24B | $13.40B | $9.72B | $9.75B | $10.34B | $10.26B | $6.70B | $7.18B | |
| SG&A Expense | $10.73B | $10.82B | $10.50B | $10.04B | $9.63B | $8.96B | $9.46B | $10.10B | $10.07B | $10.02B | $10.31B | $11.61B | |
| Interest Expense | · | · | $1.15B | $962M | $806M | $831M | $893M | $772M | $754M | $693M | $672M | $732M | |
| Interest Income | $343M | $415M | $365M | $157M | $36M | $59M | $274M | $343M | $385M | $328M | $289M | $266M | |
| Other Non-op | $-151M | $24M | $-466M | $-1.50B | $1.34B | $890M | $-129M | $402M | $500M | $-189M | $-1.53B | $11.61B | |
| Pretax Income | $21.07B | $19.94B | $1.89B | $16.44B | $13.88B | $5.86B | $7.17B | $8.70B | $6.52B | $4.66B | $5.40B | $17.28B | |
| Income Tax | $2.80B | $2.80B | $1.51B | $1.92B | $1.52B | $1.34B | $1.56B | $2.51B | $4.10B | $718M | $942M | $5.35B | |
| Net Income | $18.25B | $17.12B | $365M | $14.52B | $13.05B | $7.07B | $9.84B | $6.22B | $2.39B | $3.92B | $4.44B | $11.92B | |
| EPS (Basic) | $7.30 | $6.76 | $0.14 | $5.73 | $5.16 | $2.79 | $3.84 | $2.34 | $0.88 | $1.42 | $1.58 | $4.12 | |
| EPS (Diluted) | $7.28 | $6.74 | $0.14 | $5.71 | $5.14 | $2.78 | $3.81 | $2.32 | $0.87 | $1.41 | $1.56 | $4.07 | |
| Shares (Basic) | 2,502,000,000 | 2,532,000,000 | 2,537,000,000 | 2,532,000,000 | 2,530,000,000 | 2,530,000,000 | 2,565,000,000 | 2,664,000,000 | 2,730,000,000 | 2,766,000,000 | 2,816,000,000 | 2,894,000,000 | |
| Shares (Diluted) | 2,507,000,000 | 2,541,000,000 | 2,547,000,000 | 2,542,000,000 | 2,538,000,000 | 2,541,000,000 | 2,580,000,000 | 2,679,000,000 | 2,748,000,000 | 2,787,000,000 | 2,841,000,000 | 2,928,000,000 | |
| EBITDA | · | · | · | · | · | · | $3.65B | $4.52B | $4.64B | $5.44B | $6.38B | $6.69B |
Stato Patrimoniale 26
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $14.56B | $13.24B | $6.84B | $12.69B | $8.10B | $8.05B | $9.68B | $7.96B | $6.09B | $6.51B | $8.52B | $7.44B | |
| Short-term Investments | $0 | $447M | $252M | $498M | $0 | $0 | $774M | $899M | $2.41B | $7.83B | $4.90B | $8.28B | |
| Receivables | $11.78B | $10.28B | $10.35B | $9.45B | $9.23B | $6.80B | $6.78B | $7.07B | $6.87B | $7.02B | $6.48B | $6.63B | |
| Inventory | $6.66B | $6.11B | $6.36B | $5.91B | $5.95B | $5.55B | $5.98B | $5.44B | $5.10B | $4.87B | $4.70B | $5.57B | |
| Other Current Assets | $10.52B | $8.71B | $8.37B | $7.17B | $6.99B | $4.67B | $4.28B | $4.50B | $4.30B | $4.39B | $5.14B | $4.69B | |
| Current Assets | $43.52B | $38.78B | $32.17B | $35.72B | $30.27B | $27.76B | $27.48B | $25.88B | $24.77B | $30.61B | $29.75B | $32.60B | |
| PP&E (Net) | $25.32B | $23.78B | $23.05B | $21.42B | $19.28B | $17.00B | $14.30B | $13.29B | $12.44B | $12.03B | $12.51B | $13.14B | |
| PP&E (Gross) | $47.23B | $42.93B | $41.32B | $39.41B | $37.47B | $35.16B | $32.74B | $29.61B | $29.04B | $27.77B | $28.43B | $31.14B | |
| Accum. Depreciation | $21.91B | $19.16B | $18.27B | $17.98B | $18.19B | $18.16B | $17.69B | $16.32B | $16.60B | $15.75B | $15.92B | $18.00B | |
| Goodwill | $21.58B | $21.67B | $21.20B | $21.20B | $21.26B | $18.88B | $18.07B | $18.25B | $18.28B | $18.16B | $17.72B | $12.99B | |
| Intangibles | $26.68B | $16.37B | $18.01B | $20.27B | $22.93B | $14.10B | $14.20B | $13.10B | $14.18B | $17.30B | $22.60B | $20.39B | |
| Other Non-current Assets | $18.82B | $16.04B | $12.00B | $9.53B | · | · | · | · | · | · | · | · | |
| Total Assets | $136.87B | $117.11B | $106.67B | $109.16B | $105.69B | $91.59B | $84.40B | $82.64B | $87.87B | $95.38B | $101.68B | $98.17B | |
| Accounts Payable | $4.40B | $4.08B | $3.92B | $4.26B | $4.61B | $4.33B | $3.74B | $3.32B | $3.10B | $2.81B | $2.53B | $2.62B | |
| Current Liabilities | $28.33B | $28.42B | $25.69B | $24.24B | $23.87B | $27.33B | $22.22B | $22.21B | $18.61B | $17.20B | $19.20B | $18.40B | |
| Capital Leases | $901M | $877M | $928M | $1.01B | $1.23B | $1.33B | $768M | · | · | · | · | · | |
| Deferred Tax | $1.44B | $1.39B | $871M | $1.79B | $3.44B | $1.00B | $1.47B | $1.70B | $2.22B | $5.08B | $6.54B | $4.47B | |
| Other Non-current Liabilities | $7.69B | $6.46B | $8.79B | $8.32B | $9.43B | $12.31B | $11.97B | $12.04B | $11.12B | $8.51B | $7.34B | $7.81B | |
| Long-term Debt | $49.05B | $36.96B | $34.98B | $30.45B | $32.99B | $27.66B | $24.64B | · | $24.35B | $24.57B | $26.13B | $19.70B | |
| Total Debt | $49.05B | $36.96B | · | $30.45B | $32.99B | $27.66B | $24.64B | $19.81B | $24.35B | $24.57B | $26.23B | $19.70B | |
| Common Stock | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | |
| Retained Earnings | $73.08B | $63.07B | $53.90B | $61.08B | $53.70B | $47.36B | $46.60B | $42.58B | $41.35B | $44.13B | $45.35B | $46.02B | |
| Treasury Stock | $63.00B | $58.30B | $57.45B | $56.49B | $57.11B | $56.79B | $55.95B | $50.93B | $43.79B | $40.55B | $38.53B | $35.26B | |
| AOCI | $-4.29B | $-4.95B | $-5.16B | $-4.77B | $-4.43B | $-6.63B | $-6.19B | $-5.54B | $-4.91B | $-5.23B | $-4.15B | $-4.32B | |
| Stockholders' Equity | $52.61B | $46.31B | $37.58B | $45.99B | $38.18B | $25.32B | $25.91B | $26.70B | $34.34B | $40.09B | $44.68B | $48.65B | |
| Liabilities + Equity | $136.87B | $117.11B | $106.67B | $109.16B | $105.69B | $91.59B | $84.40B | $82.64B | $87.87B | $95.38B | $101.68B | $98.17B |
Flusso di cassa 18
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $3.65B | $4.52B | $4.68B | $5.47B | $6.38B | $6.69B | |
| Stock-based Comp | $820M | $761M | $645M | $541M | $479M | $441M | $388M | $348M | $312M | $300M | $299M | $278M | |
| Deferred Tax | $-1.67B | $-1.25B | $-1.90B | $-1.57B | $187M | $-566M | $-560M | $-509M | $-2.62B | $-1.52B | $-764M | $-2.60B | |
| Amort. of Intangibles | $2.80B | $2.40B | $2.00B | $2.10B | $1.60B | $1.80B | $1.70B | $3.10B | $3.20B | $3.80B | $4.80B | $4.20B | |
| Restructuring | $889M | $309M | $599M | $337M | $661M | $575M | $626M | $632M | $776M | $651M | $619M | $1.01B | |
| Other Non-cash | · | · | · | · | · | · | $84M | $344M | $1.73B | $2.24B | $2.07B | $-8.43B | |
| Operating Cash Flow | $16.47B | $21.47B | $13.01B | $19.09B | $13.12B | $7.62B | $8.88B | $10.92B | $6.45B | $10.38B | $12.54B | $7.99B | |
| CapEx | $4.11B | $3.37B | $3.86B | $4.39B | $4.45B | $4.43B | $3.37B | $2.62B | $1.89B | $1.61B | $1.28B | $1.32B | |
| Investing Cash Flow | $-13.74B | $-7.73B | $-14.08B | $-4.96B | · | $-9.44B | $-2.63B | $4.31B | $2.68B | $-3.21B | $-4.76B | $-374M | |
| Debt Issued | · | · | $5.94B | $0 | $7.94B | $4.42B | $4.96B | $0 | $0 | $1.08B | $7.94B | $3.15B | |
| Net Debt Issued | $-2.50B | $-1.29B | · | $-2.25B | $5.62B | $2.46B | $4.96B | $-4.29B | $-1.10B | $-1.31B | $5.03B | $-3.47B | |
| Stock Repurchased | $5.08B | $1.31B | $1.35B | $0 | $840M | $1.28B | $4.78B | $9.09B | $4.01B | $3.43B | $4.19B | $7.70B | |
| Net Stock Activity | $-5.08B | $-1.31B | · | $0 | $-840M | $-1.28B | $-4.78B | $-9.09B | $-4.01B | $-3.43B | $-4.19B | $-7.70B | |
| Dividends Paid | $8.18B | $7.84B | $7.45B | $7.01B | $6.61B | $6.21B | $5.70B | $5.17B | $5.17B | $5.12B | $5.12B | $5.17B | |
| Financing Cash Flow | $-1.92B | $-7.03B | $-4.81B | $-9.12B | · | $-2.83B | $-8.86B | $-13.16B | $-10.01B | $-9.04B | $-5.39B | $-15.24B | |
| Net Change in Cash | $1.37B | $6.41B | $-5.86B | $4.61B | $14M | $-1.77B | $1.97B | $1.87B | $-419M | $-2.01B | $1.08B | $-8.18B | |
| Free Cash Flow | $12.36B | $18.10B | · | $14.71B | $8.67B | $5.57B | $9.97B | $8.31B | $4.56B | $8.76B | $11.14B | $6.54B | |
| Levered FCF | · | · | · | $13.86B | $7.96B | $4.90B | $9.21B | $7.76B | $4.28B | $8.18B | $10.58B | $6.04B |
Redditività 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 28.1% | 26.7% | · | 24.5% | 26.8% | 14.7% | 21.0% | 14.7% | 6.0% | 9.8% | 11.2% | 28.2% | |
| Pretax Margin | 32.4% | 31.1% | · | 27.7% | 28.5% | 18.3% | 24.5% | 20.6% | 16.2% | 11.7% | 13.7% | 40.9% | |
| EBITDA Margin | · | · | · | · | · | · | 7.8% | 10.7% | 11.6% | 13.7% | 16.1% | 15.8% | |
| ROA | 14.4% | 15.3% | · | 13.5% | 13.2% | 8.0% | 11.8% | 7.3% | 2.6% | 4.0% | 4.4% | 11.7% | |
| ROE | 36.9% | 40.8% | · | 34.5% | 41.1% | 27.6% | 37.4% | 20.4% | 6.4% | 9.2% | 9.5% | 24.2% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.5 | 1.3 | 1.0 | 1.2 | 1.2 | 1.3 | 1.8 | 1.6 | 1.8 | |
| Quick Ratio | 0.9 | 0.8 | · | 0.9 | 0.7 | 0.6 | 0.8 | 0.7 | 0.8 | 1.2 | 1.0 | 1.2 | |
| Debt / Equity | 0.9 | 0.8 | · | 0.7 | 0.9 | 1.1 | 1.0 | 0.7 | 0.7 | 0.6 | 0.6 | 0.4 | |
| LT Debt / Equity | 0.9 | 0.7 | · | 0.6 | 0.8 | 1.0 | 0.9 | 0.7 | 0.6 | 0.6 | 0.5 | 0.4 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.5 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | |
| Inventory Turnover | 2.6 | 2.4 | · | 2.9 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | 2.9 | 2.9 | 2.8 | |
| Receivables Turnover | 5.9 | 6.2 | · | 6.3 | 6.1 | 6.6 | 6.8 | 6.1 | 5.8 | 5.9 | 6.0 | 6.1 |
Tassi di Crescita 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 1.3% | 6.7% | 1.4% | 21.7% | 17.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 3.1% | 9.6% | 13.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 8.0% | 4714.3% | -97.5% | 11.1% | 84.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 8.4% | 9.4% | -63.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 6.6% | 4589.6% | -97.5% | 11.3% | 84.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 7.9% | 9.5% | -62.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 20.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.6% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 6
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $65.01B | $64.17B | $60.12B | $59.28B | $48.70B | $41.52B | $39.12B | $42.29B | $40.12B | $39.81B | $39.50B | $42.24B | |
| Net Income TTM | $18.25B | $17.12B | $365M | $14.52B | $13.05B | $7.07B | $9.84B | $6.22B | $2.39B | $3.92B | $4.44B | $11.92B | |
| P/E | 14.5 | 14.8 | 778.7 | 19.4 | 14.9 | 28.1 | 22.8 | 31.4 | 61.7 | 39.8 | 32.3 | 13.3 | |
| Earnings Yield | 6.9% | 6.8% | 0.13% | 5.1% | 6.7% | 3.6% | 4.4% | 3.2% | 1.6% | 2.5% | 3.1% | 7.5% | |
| Payout Ratio | 44.8% | 45.8% | · | 48.3% | 50.7% | 87.9% | 57.9% | 83.2% | 215.8% | 130.7% | 115.2% | 43.4% | |
| Annual Payout | $8.18B | $7.84B | $7.45B | $7.01B | $6.61B | $6.21B | $5.70B | $5.17B | $5.17B | $5.12B | $5.12B | $5.17B |
Conto Economico 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.61B | $16.29B | $16.40B | $17.28B | $15.81B | $15.53B | $15.62B | $16.66B | $16.11B | $15.78B | $14.63B | $15.96B | $15.04B | $14.49B | $13.83B | $14.96B | |
| Cost of Revenue | $4.39B | $4.20B | $5.55B | $3.85B | $3.56B | $3.42B | $3.83B | $4.08B | $3.75B | $3.54B | $3.91B | $4.26B | $4.02B | $3.93B | $3.88B | $3.93B | |
| R&D Expense | $9.74B | $12.59B | $3.89B | $4.23B | $4.05B | $3.62B | $4.58B | $5.86B | $3.50B | $3.99B | $9.63B | $3.31B | $13.32B | $4.28B | $3.77B | $4.40B | |
| SG&A Expense | $2.90B | $2.70B | $2.90B | $2.63B | $2.65B | $2.55B | $2.86B | $2.73B | $2.74B | $2.48B | $2.80B | $2.52B | $2.70B | $2.48B | $2.69B | $2.52B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $303M | · | $317M | $277M | $242M | · | $244M | |
| Interest Income | $35M | $35M | $69M | $96M | $69M | $109M | $146M | $127M | $69M | $73M | $71M | $73M | $109M | $112M | $95M | $40M | |
| Other Non-op | $-99M | $-138M | $-431M | $238M | $7M | $35M | $-129M | $162M | $-42M | $33M | $-79M | $-126M | $-172M | $-89M | $74M | $-429M | |
| Pretax Income | $-683M | $-3.53B | $3.42B | $6.75B | $5.00B | $5.90B | $4.17B | $4.09B | $6.01B | $5.67B | $-2.05B | $5.62B | $-5.33B | $3.65B | $3.51B | $3.58B | |
| Income Tax | $654M | $709M | $457M | $958M | $571M | $818M | $426M | $929M | $545M | $903M | $-820M | $870M | $637M | $825M | $496M | $330M | |
| Net Income | $-1.33B | $-4.24B | $2.96B | $5.79B | $4.43B | $5.08B | $3.74B | $3.16B | $5.46B | $4.76B | $-1.23B | $4.75B | $-5.97B | $2.82B | $3.02B | $3.25B | |
| EPS (Basic) | $-0.54 | $-1.72 | $1.21 | $2.32 | $1.76 | $2.01 | $1.48 | $1.25 | $2.15 | $1.88 | $-0.49 | $1.87 | $-2.35 | $1.11 | $1.19 | $1.28 | |
| EPS (Diluted) | $-0.54 | $-1.72 | $1.19 | $2.32 | $1.76 | $2.01 | $1.49 | $1.24 | $2.14 | $1.87 | $-0.48 | $1.86 | $-2.35 | $1.11 | $1.18 | $1.28 | |
| Shares (Basic) | 2,470,000,000 | 2,472,000,000 | -5,026,000,000 | 2,495,000,000 | 2,510,000,000 | 2,523,000,000 | -5,069,000,000 | 2,534,000,000 | 2,534,000,000 | 2,533,000,000 | -5,077,000,000 | 2,537,000,000 | 2,539,000,000 | 2,538,000,000 | -5,060,000,000 | 2,533,000,000 | |
| Shares (Diluted) | 2,470,000,000 | 2,472,000,000 | -5,035,000,000 | 2,498,000,000 | 2,513,000,000 | 2,531,000,000 | -5,088,000,000 | 2,541,000,000 | 2,544,000,000 | 2,544,000,000 | -5,089,000,000 | 2,546,000,000 | 2,539,000,000 | 2,551,000,000 | -5,077,000,000 | 2,542,000,000 |
Stato Patrimoniale 26
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.85B | $5.33B | $14.56B | $18.17B | $8.01B | $8.63B | $13.24B | $14.59B | $11.30B | $5.58B | · | $8.61B | $5.66B | $9.71B | · | $11.14B | |
| Short-term Investments | $292M | $375M | $0 | $45M | $615M | $599M | $447M | $0 | $50M | $40M | · | $168M | $718M | $680M | · | $103M | |
| Receivables | $12.56B | $12.21B | $11.78B | $12.12B | $11.85B | $10.79B | $10.28B | $11.38B | $11.64B | $11.37B | · | $10.39B | $11.03B | $10.41B | · | $9.48B | |
| Inventory | $6.21B | $6.48B | $6.66B | $6.44B | $6.60B | $6.20B | $6.11B | $6.24B | $6.47B | $6.51B | · | $6.13B | $5.93B | $5.86B | · | $5.61B | |
| Other Current Assets | $10.77B | $10.62B | $10.52B | $10.78B | $10.00B | $9.29B | $8.71B | $8.14B | $8.74B | $7.95B | · | $6.66B | · | · | · | · | |
| Current Assets | $36.68B | $35.02B | $43.52B | $47.56B | $37.06B | $35.50B | $38.78B | $40.36B | $38.20B | $31.45B | · | $31.95B | $29.98B | $33.40B | · | $33.56B | |
| PP&E (Net) | $25.74B | $25.43B | $25.32B | $25.64B | $25.24B | $24.79B | $23.78B | $23.45B | $23.22B | $23.05B | $23.05B | $22.53B | $22.23B | $21.76B | $21.42B | $20.42B | |
| PP&E (Gross) | · | · | $47.23B | · | · | · | $42.93B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $22.73B | $22.29B | $21.91B | $20.61B | $20.26B | $19.68B | $19.16B | $19.07B | $18.96B | $18.62B | · | $18.45B | $18.43B | $18.26B | · | $17.92B | |
| Goodwill | $21.58B | $21.58B | $21.58B | $21.59B | $21.59B | $21.68B | $21.67B | $21.70B | $21.16B | $21.18B | $21.20B | $21.18B | $21.20B | $21.21B | $21.20B | $21.16B | |
| Intangibles | $24.98B | $25.75B | $26.68B | $15.31B | $15.19B | $15.76B | $16.37B | $17.01B | $16.98B | $17.57B | · | $19.20B | $19.66B | $19.86B | · | $21.37B | |
| Other Non-current Assets | $19.60B | $19.81B | $18.82B | $18.33B | $17.66B | $16.77B | $16.04B | $14.44B | $12.70B | $12.33B | · | $10.56B | · | · | · | · | |
| Total Assets | $129.80B | $128.69B | $136.87B | $129.55B | $117.52B | $115.12B | $117.11B | $117.53B | $112.63B | $105.85B | · | $106.73B | $104.47B | $107.80B | · | $107.08B | |
| Accounts Payable | $3.83B | $3.86B | $4.40B | $4.15B | $3.89B | $3.78B | $4.08B | $3.59B | $3.52B | $3.51B | · | $3.51B | $3.44B | $3.68B | · | $3.37B | |
| Current Liabilities | $27.73B | $26.95B | $28.33B | $28.63B | $26.04B | $25.17B | $28.42B | $29.59B | $26.06B | $25.10B | · | $23.09B | $23.39B | $23.13B | · | $23.00B | |
| Capital Leases | · | · | $901M | · | · | · | $877M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $1.43B | $1.49B | $1.44B | $1.38B | $1.43B | $1.41B | $1.39B | $864M | $876M | $922M | · | $1.02B | $996M | $1.44B | · | $2.42B | |
| Other Non-current Liabilities | $7.57B | $7.64B | $7.69B | $7.66B | $7.03B | $6.66B | $6.46B | $7.54B | $7.33B | $8.26B | · | $7.34B | $7.26B | $8.24B | · | $8.66B | |
| Long-term Debt | · | · | $49.05B | · | · | · | $36.96B | · | · | · | · | · | · | · | · | · | |
| Total Debt | $51.08B | $46.67B | · | $39.97B | $33.97B | $33.48B | · | $34.98B | $34.72B | $31.14B | · | $33.97B | $34.07B | $28.07B | · | $28.48B | |
| Common Stock | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | $1.79B | · | $1.79B | $1.79B | $1.79B | · | $1.79B | |
| Retained Earnings | $63.27B | $66.72B | $73.08B | $72.23B | $68.48B | $66.10B | $63.07B | $61.38B | $60.19B | $56.70B | · | $57.08B | $54.20B | $62.04B | · | $59.93B | |
| Treasury Stock | $64.13B | $63.75B | $63.00B | $61.80B | $60.49B | $59.40B | $58.30B | $57.83B | $57.39B | $57.45B | · | $57.07B | $56.61B | $56.58B | · | $56.76B | |
| AOCI | $-3.94B | $-4.06B | $-4.29B | $-5.20B | $-5.42B | $-4.96B | $-4.95B | $-5.37B | $-5.36B | $-5.27B | · | $-4.92B | $-4.90B | $-4.88B | · | $-4.74B | |
| Stockholders' Equity | $41.93B | $45.88B | $52.61B | $51.85B | $48.99B | $48.34B | $46.31B | $44.50B | $43.58B | $40.36B | · | $41.25B | $38.69B | $46.83B | · | $44.46B | |
| Liabilities + Equity | $129.80B | $128.69B | $136.87B | $129.55B | $117.52B | $115.12B | $117.11B | $117.53B | $112.63B | $105.85B | · | $106.73B | $104.47B | $107.80B | · | $107.08B |
Flusso di cassa 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $298M | $185M | $205M | $204M | $216M | $195M | $187M | $195M | $203M | $176M | $167M | $164M | $169M | $145M | $145M | $139M | |
| Deferred Tax | $-544M | $-315M | $-825M | $-212M | $-448M | $-186M | $-616M | $-401M | $-181M | $-51M | $-931M | $-336M | $-355M | $-277M | $-307M | $-661M | |
| Restructuring | $151M | $195M | $213M | $47M | $560M | $69M | $50M | $56M | $80M | $123M | $255M | $126M | $151M | $67M | $48M | $94M | |
| Operating Cash Flow | $5.37B | $3.92B | $2.86B | $7.82B | $3.29B | $2.50B | $3.45B | $9.29B | $5.64B | $3.09B | $246M | $7.72B | $3.70B | $1.34B | $4.43B | $5.60B | |
| CapEx | $893M | $991M | $1.03B | $987M | $764M | $1.33B | $937M | $783M | $791M | $861M | $989M | $902M | $965M | $1.01B | $1.15B | $1.13B | |
| Investing Cash Flow | $-5.60B | $-10.21B | $-11.20B | $-283M | $-770M | $-1.49B | $-1.44B | $-3.85B | $-1.07B | $-1.38B | $53M | $-334M | $-11.44B | $-2.36B | $-1.75B | $-962M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $0 | |
| Net Debt Issued | · | $-1.14B | · | · | · | $-2.50B | · | · | · | $-751M | · | · | · | $-1M | · | · | |
| Stock Repurchased | $757M | $874M | $1.25B | $1.32B | $1.34B | $1.16B | $489M | $444M | $251M | $122M | $393M | $466M | $338M | $149M | $0 | $0 | |
| Net Stock Activity | · | $-874M | · | · | · | $-1.16B | · | · | · | $-122M | · | · | · | $-149M | · | · | |
| Dividends Paid | $2.14B | $2.10B | $2.02B | $2.03B | $2.08B | $2.05B | $1.95B | $1.95B | $1.99B | $1.95B | $1.85B | $1.85B | $1.89B | $1.85B | $1.75B | $1.75B | |
| Financing Cash Flow | $1.76B | $-2.98B | $4.75B | $2.64B | $-3.56B | $-5.75B | $-3.01B | $-2.42B | $1.22B | $-2.81B | $-2.25B | $-4.27B | $3.76B | $-2.05B | $-1.55B | $-2.70B | |
| Net Change in Cash | $1.49B | $-9.29B | $-3.57B | $10.19B | $-659M | $-4.59B | $-1.37B | $3.31B | $5.70B | $-1.24B | $-1.76B | $2.96B | $-4.07B | $-2.99B | $1.49B | $1.53B | |
| Free Cash Flow | · | $2.93B | · | · | · | $1.17B | · | · | · | $2.23B | · | · | · | $332M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.97B | · | · | · | $145M | · | · |
Redditività 4
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -8.0% | -26.0% | · | 33.5% | 28.0% | 32.7% | · | 18.9% | 33.9% | 30.2% | · | 29.7% | -39.7% | 19.5% | · | 21.7% | |
| Pretax Margin | -4.1% | -21.7% | · | 39.0% | 31.6% | 38.0% | · | 24.6% | 37.3% | 35.9% | · | 35.2% | -35.5% | 25.2% | · | 23.9% | |
| ROA | -1.1% | -3.5% | · | 4.7% | 3.9% | 4.6% | · | 2.8% | 5.0% | 4.5% | · | 4.4% | -5.7% | 2.6% | · | 3.2% | |
| ROE | -2.9% | -9.0% | · | 12.0% | 9.6% | 11.5% | · | 7.4% | 13.3% | 10.9% | · | 11.1% | -14.6% | 6.4% | · | 8.1% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | · | 1.7 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.3 | · | 1.4 | 1.3 | 1.4 | · | 1.5 | |
| Quick Ratio | 0.7 | 0.7 | · | 1.1 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.7 | · | 0.8 | 0.7 | 0.9 | · | 0.9 | |
| Debt / Equity | 1.2 | 1.0 | · | 0.8 | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.6 | · | 0.6 | |
| LT Debt / Equity | 1.2 | 1.0 | · | 0.8 | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.6 | · | 0.6 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.7 | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.3 | 1.4 | · | 1.5 | 1.4 | 1.4 | · | 1.6 | 1.5 | 1.4 | · | 1.7 |
Valutazione (TTM) 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $65.97B | $64.90B | · | $65.27B | $64.10B | $64.07B | · | $64.51B | $62.88B | $61.26B | · | $60.44B | $59.07B | $59.94B | · | $58.61B | |
| Net Income TTM | $4.64B | $11.05B | · | $18.45B | $18.12B | $18.45B | · | $18.12B | $8.99B | $6.35B | · | $4.84B | $4.04B | $14.32B | · | $16.07B | |
| P/E | 70.6 | 27.5 | · | 11.5 | 11.1 | 12.4 | · | 16.0 | 35.2 | 53.0 | · | 54.2 | 72.6 | 18.9 | · | 13.6 | |
| Earnings Yield | 1.4% | 3.6% | · | 8.7% | 9.0% | 8.1% | · | 6.3% | 2.8% | 1.9% | · | 1.8% | 1.4% | 5.3% | · | 7.3% | |
| Payout Ratio | · | -49.6% | · | · | · | 40.4% | · | · | · | 40.9% | · | · | · | 65.7% | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $65.01B | $64.17B | $60.12B | $59.28B | $48.70B |
| Utile netto | $18.25B | $17.12B | $365M | $14.52B | $13.05B |
| EPS Diluito | $7.28 | $6.74 | $0.14 | $5.71 | $5.14 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.9 | 0.8 | — | 0.7 | 0.9 |
| Rapporto corrente | 1.5 | 1.4 | — | 1.5 | 1.3 |
| Quick Ratio | 0.9 | 0.8 | — | 0.9 | 0.7 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $12.36B | $18.10B | — | $14.71B | $8.67B |
Ultime notizie Notizie recenti che menzionano questa società
- Is Merck & Co. (MRK) One of the Best Cheap Stocks to Buy for Beginners?
- Il trial di Fase 3 TroFuse-005 di Merck (MRK) per il cancro endometriale raggiunge gli endpoint primari
- Analista Aumenta Prezzo Obiettivo Merck (MRK) di $1 Dopo Aver Superato le Stime del Q1
- Merck & Co. Inc. (MRK): Uno dei Migliori Titoli a Basso Rischio e Alta Crescita da Comprare Subito
- Jim Cramer Dice "Merck È Magnifica"
- UBS Aumenta la Previsione di Prezzo di Merck (MRK) come Parte dell'Anteprima del Settore
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 4.129 filer · $150.2B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 185 (-173 vs trimestre precedente) | 110 (-8 vs trimestre precedente) | 1.583 (+159 vs trimestre precedente) | 1.442 (-125 vs trimestre precedente) | +327.0M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $20.730.027.859 | 161.323.174 | 13,80% | Azioni |
| STATE STREET CORP | $15.573.753.504 | 120.413.256 | 10,37% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $10.321.764.299 | 80.325.014 | 6,87% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8.704.457.517 | 67.738.969 | 5,79% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $6.751.244.864 | 52.623.892 | 4,49% | Azioni |
| Fisher Asset Management, LLC | $4.949.339.962 | 38.516.263 | 3,29% | Azioni |
| NORGES BANK | $4.752.416.244 | 36.983.784 | 3,16% | Azioni |
| FMR LLC | $3.132.935.933 | 24.380.824 | 2,09% | Azioni |
| Capital International Investors | $1.977.446.105 | 15.386.689 | 1,32% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $1.922.817.650 | 14.963.562 | 1,28% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $1.782.206.207 | 13.869.309 | 1,19% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $1.579.641.303 | 13.131.942 | 1,05% | Azioni |
| AMERIPRISE FINANCIAL INC | $1.522.828.539 | 11.849.396 | 1,01% | Azioni |
| BANK OF AMERICA CORP /DE/ | $1.414.766.661 | 11.009.857 | 0,94% | Azioni |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $1.237.455.000 | 9.630.000 | 0,82% | Azioni |
| BlackRock, Inc. | $904.381.201 | 7.037.986 | 0,60% | Azioni |
| Swiss National Bank | $896.062.754 | 6.973.251 | 0,60% | Azioni |
| Grantham, Mayo, Van Otterloo & Co. LLC | $871.873.732 | 6.785.008 | 0,58% | Azioni |
| UBS Group AG | $852.504.338 | 6.634.275 | 0,57% | Azioni |
| Aristotle Capital Management, LLC | $845.353.780 | 6.578.570 | 0,56% | Azioni |
| Mitsubishi UFJ Asset Management Co., Ltd. | $794.576.951 | 6.184.340 | 0,53% | Azioni |
| Sumitomo Mitsui Trust Group, Inc. | $792.730.250 | 6.169.107 | 0,53% | Azioni |
| Legal & General Group Plc | $786.751.919 | 6.122.583 | 0,52% | Azioni |
| GOLDMAN SACHS GROUP INC | $758.234.348 | 5.900.656 | 0,50% | Azioni |
| National Pension Service | $744.243.987 | 5.791.782 | 0,50% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $718.733.268 | 5.593.255 | 0,48% | Azioni |
| Vanguard Global Advisers, LLC | $708.361.133 | 5.512.538 | 0,47% | Azioni |
| California Public Employees Retirement System | $693.738.604 | 5.398.744 | 0,46% | Azioni |
| JANE STREET GROUP, LLC | $656.609.300 | 5.109.800 | 0,44% | Opzione Put |
| AMERICAN CENTURY COMPANIES INC | $625.276.901 | 4.865.967 | 0,42% | Azioni |
| BARCLAYS PLC | $581.939.240 | 4.528.710 | 0,39% | Azioni |
| JANE STREET GROUP, LLC | $575.718.550 | 4.480.300 | 0,38% | Opzione Call |
| Caisse de depot et placement du Quebec | $571.581.750 | 4.448.107 | 0,38% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $536.693.614 | 4.176.604 | 0,36% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $532.489.223 | 4.143.885 | 0,35% | Azioni |
| PeakShares LLC | $516.313.000 | 4.018 | 0,34% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $513.599.135 | 3.996.890 | 0,34% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $509.698.206 | 3.966.523 | 0,34% | Azioni |
| LPL Financial LLC | $493.020.235 | 3.836.733 | 0,33% | Azioni |
| PNC Financial Services Group, Inc. | $491.367.167 | 3.823.869 | 0,33% | Azioni |
| RHUMBLINE ADVISERS | $489.523.018 | 3.809.518 | 0,33% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $488.705.089 | 3.803.152 | 0,33% | Azioni |
| THORNBURG INVESTMENT MANAGEMENT INC | $486.754.916 | 3.787.976 | 0,32% | Azioni |
| Bank Julius Baer & Co. Ltd, Zurich | $480.279.543 | 3.729.950 | 0,32% | Azioni |
| HighTower Advisors, LLC | $472.869.672 | 3.679.920 | 0,31% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $461.385.767 | 3.835.612 | 0,31% | Azioni |
| CITADEL ADVISORS LLC | $447.912.450 | 3.485.700 | 0,30% | Opzione Call |
| NEUBERGER BERMAN GROUP LLC | $443.015.598 | 3.446.800 | 0,29% | Azioni |
| Ensign Peak Advisors, Inc | $432.380.784 | 3.364.831 | 0,29% | Azioni |
| AVIVA PLC | $419.437.621 | 3.264.106 | 0,28% | Azioni |
| NORDEA INVESTMENT MANAGEMENT AB | $407.966.347 | 3.211.322 | 0,27% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $402.325.404 | 3.130.937 | 0,27% | Azioni |
| ROYAL LONDON ASSET MANAGEMENT LTD | $383.834.263 | 2.987.037 | 0,26% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $373.911.742 | 2.909.819 | 0,25% | Azioni |
| JENNISON ASSOCIATES LLC | $350.671.044 | 2.728.958 | 0,23% | Azioni |
| Assenagon Asset Management S.A. | $347.334.472 | 2.702.992 | 0,23% | Azioni |
| Mariner, LLC | $346.849.966 | 2.699.099 | 0,23% | Azioni |
| FIRST TRUST ADVISORS LP | $333.053.353 | 2.591.856 | 0,22% | Azioni |
| Alyeska Investment Group, L.P. | $318.755.815 | 2.480.590 | 0,21% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $316.128.005 | 2.457.081 | 0,21% | Azioni |
| Eurizon Capital SGR S.p.A. | $308.695.812 | 2.398.834 | 0,21% | Azioni |
| Robeco Institutional Asset Management B.V. | $305.058.122 | 2.373.993 | 0,20% | Azioni |
| MACKENZIE FINANCIAL CORP | $304.985.884 | 2.373.431 | 0,20% | Azioni |
| TD Asset Management Inc | $300.012.291 | 2.334.726 | 0,20% | Azioni |
| Smead Capital Management, Inc. | $299.979.141 | 2.334.468 | 0,20% | Azioni |
| BANK OF MONTREAL /CAN/ | $297.073.239 | 2.311.854 | 0,20% | Azioni |
| JANUS HENDERSON GROUP PLC | $284.641.385 | 2.366.293 | 0,19% | Azioni |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $275.099.611 | 2.140.853 | 0,18% | Azioni |
| BANK OF NOVA SCOTIA | $272.246.099 | 2.118.646 | 0,18% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $266.403.116 | 2.073.176 | 0,18% | Azioni |
| Aberdeen Group plc | $264.474.588 | 2.058.168 | 0,18% | Azioni |
| CAPTRUST FINANCIAL ADVISORS | $263.988.216 | 2.054.383 | 0,18% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $260.857.956 | 2.030.023 | 0,17% | Azioni |
| Cullen Capital Management, LLC | $259.158.168 | 2.016.795 | 0,17% | Azioni |
| APG Asset Management N.V. | $253.945.357 | 2.259.422 | 0,17% | Azioni |
| Capital Research Global Investors | $247.364.171 | 1.925.013 | 0,16% | Azioni |
| PRUDENTIAL FINANCIAL INC | $245.433.073 | 1.909.985 | 0,16% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $244.871.555 | 1.912.337 | 0,16% | Azioni |
| Nuveen, LLC | $244.496.631 | 1.902.698 | 0,16% | Azioni |
| CITADEL ADVISORS LLC | $243.534.357 | 1.895.209 | 0,16% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $242.026.848 | 2.012.028 | 0,16% | Azioni |
| Capital Wealth Planning, LLC | $241.414.107 | 1.878.709 | 0,16% | Azioni |
| Korea Investment CORP | $239.190.543 | 1.861.405 | 0,16% | Azioni |
| LAZARD ASSET MANAGEMENT LLC | $236.603.326 | 1.841.271 | 0,16% | Azioni |
| CITIGROUP INC | $218.861.200 | 1.703.200 | 0,15% | Opzione Put |
| STOREBRAND ASSET MANAGEMENT AS | $216.639.564 | 1.685.911 | 0,14% | Azioni |
| SEB Asset Management AB | $212.802.920 | 1.656.056 | 0,14% | Azioni |
| Alecta Tjanstepension Omsesidigt | $210.598.117 | 1.640.300 | 0,14% | Azioni |
| Quantinno Capital Management LP | $195.732.858 | 1.523.212 | 0,13% | Azioni |
| FIFTH THIRD BANCORP | $192.829.582 | 1.500.619 | 0,13% | Azioni |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $190.474.908 | 1.482.295 | 0,13% | Azioni |
| Mondrian Investment Partners LTD | $189.401.933 | 1.473.945 | 0,13% | Azioni |
| DJE Kapital AG | $187.479.427 | 1.431.324 | 0,12% | Azioni |
| Pictet Asset Management Holding SA | $186.518.393 | 1.451.505 | 0,12% | Azioni |
| CIBC WORLD MARKET INC. | $186.004.690 | 1.447.507 | 0,12% | Azioni |
| Mitsubishi UFJ Trust & Banking Corp | $184.639.851 | 1.436.886 | 0,12% | Azioni |
| TORONTO DOMINION BANK | $184.538.465 | 1.436.097 | 0,12% | Azioni |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $183.546.956 | 1.625.531 | 0,12% | Azioni |
| Candriam S.C.A. | $182.227.428 | 1.419.478 | 0,12% | Azioni |
| Focus Partners Wealth | $176.831.683 | 1.375.512 | 0,12% | Azioni |
Insider aziendali 110 insider · 56 dirigenti · 40 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert M Davis | Chairman, CEO & President | 05 Maggio 2026 A | 450.351 | 0 | 2 | $-5.599.291 |
| Fred Hassan | Chairman and CEO | 03 Novembre 2009 D | 0 | 0 | 0 | $0 |
| Caroline Litchfield | EVP & CFO | 05 Maggio 2026 A | 92.301 | 0 | 1 | $-5.023.261 |
| KELLOGG PETER N | Exe V-P & CFO | 24 Febbraio 2014 A | 149.554 | 0 | 0 | $0 |
| Joseph Romanelli | President, Human Health Int?l | 26 Gennaio 2026 A | 28.739 | 0 | 0 | $0 |
| Brian Foard | EVP, Specialty, Pharma, & ID | 05 Maggio 2026 A | — | 0 | 0 | $0 |
| Dalton E. Smart III | SVP Fin. - Global Controller | 05 Maggio 2026 A | 9.388 | 0 | 2 | $-765.952 |
| Johannes Jacobus Oosthuizen | EVP, Oncology & Int?l | 05 Maggio 2026 A | 21.895 | 0 | 1 | $-1.828.050 |
| Dean Y Li | Executive VP & President, MRL | 05 Maggio 2026 A | 94.431 | 0 | 2 | $-2.994.700 |
| Betty D Larson | EVP, Chief HR Officer | 05 Maggio 2026 A | 13.774 | 0 | 0 | $0 |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | 29 Aprile 2026 M | 15.347 | 0 | 0 | $0 |
| Cristal N Downing | Chief Comm. & Public Afrs Ofcr | 10 Novembre 2025 S | 0 | 0 | 1 | $-616.395 |
| Michael A Klobuchar | EVP - Chief Strategy Officer | 04 Maggio 2024 M | 23.621 | 0 | 0 | $0 |
| Steven Mizell | EVP, Chief HR Officer | 02 Febbraio 2024 M | 23.619 | 0 | 0 | $0 |
| Lisa Lecointe-Cephas | SVP Chief Ethics & Com Officer | 04 Maggio 2023 M | 5.142 | 0 | 0 | $0 |
| Rita A Karachun | Sr. VP Fince-Global Controller | 04 Maggio 2023 M | 45.710 | 0 | 0 | $0 |
| Kenneth C Frazier | Executive Chair | 07 Novembre 2022 M | 700.653 | 0 | 0 | $0 |
| Arpa Garay | SVP Human Health Global Mktg. | 03 Maggio 2022 A | 2.109 | 0 | 0 | $0 |
| Julie L. Gerberding | EVP, Chief Patient Officer | 24 Febbraio 2022 A | 48.712 | 0 | 0 | $0 |
| Frank Clyburn | EVP & Pres ? Human Health | 04 Maggio 2021 A | 97.095 | 0 | 0 | $0 |
| Michael Fleming | SVP Chief Ethics & Com Officer | 26 Febbraio 2021 A | 10.283 | 0 | 0 | $0 |
| Michael Nally | EVP, Chief Marketing Officer | 26 Febbraio 2021 A | 19.630 | 0 | 0 | $0 |
| Roger M Perlmutter | Exe V-P & Pres, MRL | 01 Maggio 2020 A | 214.428 | 0 | 0 | $0 |
| Clark Golestani | EVP & Chief Info Officer | 10 Agosto 2016 S | 14.083 | 0 | 0 | $0 |
| Michael Rosenblatt | Exec V-P & Chief Med Officer | 10 Maggio 2016 A | 41.133 | 0 | 0 | $0 |
| Willie A Deese | Exe V-P & Pres. MMD | 22 Febbraio 2016 A | 133.759 | 0 | 0 | $0 |
| Bruce N Kuhlik | Exe V-P & Gen Counsel | 04 Maggio 2015 M | 150.432 | 0 | 0 | $0 |
| Bridgette P Heller | Exe.VP & Pres.Con.Hlth.Care | 09 Maggio 2014 A | 35.474 | 0 | 0 | $0 |
| John Canan | Sr.V-P Finc-Global Controller | 24 Febbraio 2014 A | 13.610 | 0 | 0 | $0 |
| DO CUONG V | EVP & Chief Strategy Officer | 06 Maggio 2013 A | — | 0 | 0 | $0 |
| Peter S Kim | Exe V-P & Pres, MRL | 25 Febbraio 2013 A | 189.609 | 0 | 0 | $0 |
| Richard S Bowles III | Exe VP&Chief Ethics & ComplOff | 10 Maggio 2012 M | 73.540 | 0 | 0 | $0 |
| Chris J Scalet | Exe V-P Global Srvs & CIO | 02 Maggio 2012 A | 79.829 | 0 | 0 | $0 |
| Raul E Kohan | Exe Vice President | 31 Dicembre 2011 F | 70.990 | 0 | 0 | $0 |
| Mervyn Turner | Chief Strategy Officer | 28 Febbraio 2011 M | 26.424 | 0 | 0 | $0 |
| Richard T Clark | Chairman | 28 Febbraio 2011 M | 108.211 | 0 | 0 | $0 |
| Stanley F Barshay | ExVP&PresConsHlthCare | 05 Marzo 2010 M | 71.589 | 0 | 0 | $0 |
| Lori A. Queisser | Senior Vice President | 03 Novembre 2009 D | — | 0 | 0 | $0 |
| Thomas P Koestler | Executive Vice President | 03 Novembre 2009 D | 0 | 0 | 0 | $0 |
| Robert J Bertolini | Executive Vice President | 03 Novembre 2009 D | 0 | 0 | 0 | $0 |
| Brent L Saunders | Senior Vice President | 03 Novembre 2009 D | — | 0 | 0 | $0 |
| Ron C Cheeley | Senior Vice President | 03 Novembre 2009 D | 0 | 0 | 0 | $0 |
| Steven H Koehler | Vice President and Controller | 03 Novembre 2009 D | 0 | 0 | 0 | $0 |
| Thomas J Sabatino JR | Executive Vice President | 03 Novembre 2009 D | 0 | 0 | 0 | $0 |
| COX CARRIE SMITH | Executive Vice President | 03 Novembre 2009 D | 0 | 0 | 0 | $0 |
| Cecil B Pickett | Vice President | 01 Settembre 2006 | — | 0 | 0 | $0 |
| Douglas F Gingerella | Vice President and Controller | 20 Marzo 2006 | — | 0 | 0 | $0 |
| Joseph C Connors | Executive Vice President | 08 Marzo 2004 G | 165.410 | 0 | 0 | $0 |
| Richard W Zahn | Vice President | 01 Dicembre 2003 M | 33.935 | 0 | 0 | $0 |
| John P Ryan | Senior Vice President | 01 Dicembre 2003 M | 52.923 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| MERCK & CO., INC., MERCK SHARP & DOHME CORP., PANAMA MERGER SUB, INC. ×5 depositi | 04 Marzo 2021 | — | Deposito iniziale | — | SEC |
| Merck Global Health Innovation Fund, LLC, Merck Sharp & Dohme Corp., Merck & Co., Inc. ×2 depositi | 11 Maggio 2016 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 322 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| GDOC · Goldman Sachs ETF Trust | 5,94% | 10.073 NS | 31 Maggio 2026 | N-PORT |
| DJD · Invesco Exchange-Traded Fund Trust | 5,76% | 222.647 SH | 08 Agosto 2026 | Giornaliero |
| IYH · iShares Trust | 5,17% | 1.481.360 SH | 08 Agosto 2026 | Giornaliero |
| FLAG · Global X Funds | 5,03% | 760 NS | 30 Aprile 2026 | N-PORT |
| DOGG · First Trust Exchange-Traded Fund IV | 4,89% | 29.384 NS | 30 Aprile 2026 | N-PORT |
| PJP · Invesco Exchange-Traded Fund Trust | 4,85% | 191.099 SH | 08 Agosto 2026 | Giornaliero |
| PAWZ · ProShares Trust | 4,84% | 13.228 NS | 31 Maggio 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 4,68% | 7.432.227 SH | 08 Agosto 2026 | Giornaliero |
| IHE · iShares Trust | 4,39% | 553.916 SH | 08 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 4,38% | 1.144.186 NS | 30 Aprile 2026 | N-PORT |
| IXJ · iShares Trust | 4,28% | 1.364.929 SH | 08 Agosto 2026 | Giornaliero |
| HRTS · Tema ETF Trust | 4,27% | 18.672 NS | 31 Maggio 2026 | N-PORT |
| RXL · ProShares Trust | 4,26% | 25.881 NS | 31 Maggio 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 4,21% | 4.289 NS | 30 Aprile 2026 | N-PORT |
| TECB · iShares Trust | 4,08% | 153.076 SH | 08 Agosto 2026 | Giornaliero |
| HDV · iShares Trust | 3,93% | 4.526.140 SH | 08 Agosto 2026 | Giornaliero |
| CURE · Direxion Shares ETF Trust | 3,91% | 49.491 NS | 30 Aprile 2026 | N-PORT |
| SCHD · SCHWAB STRATEGIC TRUST | 3,86% | 30.860.833 NS | 31 Maggio 2026 | N-PORT |
| TBG · EA Series Trust | 3,74% | 78.875 NS | 30 Aprile 2026 | N-PORT |
| IDNA · iShares Trust | 3,72% | 57.270 SH | 08 Agosto 2026 | Giornaliero |
| CANC · Tema ETF Trust | 3,57% | 52.978 NS | 31 Maggio 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 3,32% | 462.586 SH | 08 Agosto 2026 | Giornaliero |
| GEND · Spinnaker ETF Series | 3,11% | 1.275 NS | 30 Aprile 2026 | N-PORT |
| AGNG · Global X Funds | 2,99% | 20.617 NS | 31 Maggio 2026 | N-PORT |
| OUSA · ALPS ETF Trust | 2,95% | 184.861 NS | 31 Maggio 2026 | N-PORT |
| VLLU · Harbor ETF Trust | 2,92% | 1.165 NS | 30 Aprile 2026 | N-PORT |
| GMOV · GMO ETF Trust | 2,73% | 20.939 NS | 31 Maggio 2026 | N-PORT |
| ICAP · Series Portfolios Trust | 2,68% | 24.553 NS | 31 Maggio 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 2,52% | 73.781 NS | 31 Maggio 2026 | N-PORT |
| QDIV · Global X Funds | 2,16% | 5.965 NS | 31 Maggio 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 2,14% | 31.237 NS | 30 Aprile 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 2,06% | 8.531 NS | 30 Aprile 2026 | N-PORT |
| LOWV · AB Active ETFs, Inc. | 2,01% | 34.680 NS | 31 Maggio 2026 | N-PORT |
| SNPV · DBX ETF Trust | 2,01% | 38.898 NS | 29 Maggio 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 2,00% | 5.048 NS | 30 Aprile 2026 | N-PORT |
| FDIV · EA Series Trust | 1,97% | 13.102 NS | 30 Aprile 2026 | N-PORT |
| SDOG · ALPS ETF Trust | 1,94% | 225.836 NS | 31 Maggio 2026 | N-PORT |
| GCOW · Pacer Funds Trust | 1,92% | 587.741 NS | 30 Aprile 2026 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 1,90% | 3.027 NS | 30 Aprile 2026 | N-PORT |
| DGRO · iShares Trust | 1,86% | 6.304.270 SH | 08 Agosto 2026 | Giornaliero |
| CCOR · Listed Funds Trust | 1,85% | 4.665 NS | 30 Aprile 2026 | N-PORT |
| QLTY · GMO ETF Trust | 1,83% | 694.466 NS | 31 Maggio 2026 | N-PORT |
| PAYR · Federated Hermes ETF Trust | 1,80% | 6.028 NS | 30 Aprile 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 1,75% | 1.899.191 NS | 31 Maggio 2026 | N-PORT |
| SMRI · EA Series Trust | 1,75% | 86.939 NS | 30 Aprile 2026 | N-PORT |
| XT · iShares Trust | 1,69% | 515.140 SH | 08 Agosto 2026 | Giornaliero |
| GINX · RBB Fund, Inc. | 1,69% | 13.508 NS | 31 Maggio 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 1,66% | 7.091 NS | 30 Aprile 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,63% | 99.511 SH | 08 Agosto 2026 | Giornaliero |
| AVIE · AMERICAN CENTURY ETF TRUST | 1,60% | 1.382 NS | 31 Maggio 2026 | N-PORT |